PASQUALI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 5.181
EU - Europa 5.144
AS - Asia 606
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 6
OC - Oceania 4
Totale 10.971
Nazione #
US - Stati Uniti d'America 5.168
IE - Irlanda 1.534
UA - Ucraina 896
GB - Regno Unito 741
SE - Svezia 477
IT - Italia 453
CN - Cina 368
DE - Germania 302
FR - Francia 283
FI - Finlandia 232
TR - Turchia 203
GR - Grecia 156
BE - Belgio 20
IN - India 12
BR - Brasile 11
NL - Olanda 11
CA - Canada 9
ES - Italia 9
EU - Europa 6
PL - Polonia 6
RU - Federazione Russa 6
EC - Ecuador 5
RO - Romania 5
BG - Bulgaria 4
EG - Egitto 4
AU - Australia 3
IR - Iran 3
MX - Messico 3
PE - Perù 3
SG - Singapore 3
TW - Taiwan 3
CO - Colombia 2
HK - Hong Kong 2
JP - Giappone 2
KR - Corea 2
LT - Lituania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
GH - Ghana 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.971
Città #
Dublin 1.532
Jacksonville 1.356
Chandler 1.039
Princeton 247
Boardman 183
Ann Arbor 179
Roxbury 164
New York 134
Medford 133
Woodbridge 133
Wilmington 123
Cambridge 119
San Mateo 81
Ashburn 68
Beijing 67
Caserta 65
Des Moines 60
Nanjing 56
Düsseldorf 53
Mountain View 47
Jinan 42
Bremen 38
Nanchang 27
Napoli 27
Naples 26
Shenyang 26
Houston 22
Brussels 20
Norwalk 20
Rome 20
Taiyuan 16
Auburn Hills 15
Hebei 15
Venice 15
Kunming 13
Guangzhou 12
Helsinki 12
Lanzhou 12
Tianjin 11
Changsha 10
Los Angeles 10
Ningbo 10
Massa Lubrense 9
Milan 9
Seattle 9
Bari 8
Zhengzhou 8
Edinburgh 7
Groningen 7
Haikou 7
Matera 7
Como 6
Florence 6
Roccapiemonte 6
Sant'antonio Abate 6
Falls Church 5
Shanghai 5
Catania 4
Cava de' Tirreni 4
Elora 4
Grammichele 4
Hyderabad 4
Pozzuoli 4
Quito 4
Radomsko 4
Redwood City 4
Sofia 4
Taizhou 4
Amsterdam 3
Aversa 3
Bologna 3
Bucharest 3
Cassino 3
Hangzhou 3
Hanover 3
Jiaxing 3
Lima 3
Orange 3
Phoenix 3
Porto Torres 3
Pune 3
Salerno 3
San Giovanni Rotondo 3
Sevilla 3
Taipei 3
Andover 2
Ankara 2
Arquata Scrivia 2
Bagnoli Irpino 2
Barranquilla 2
Buccinasco 2
Casagiove 2
Casale Monferrato 2
Castel San Giorgio 2
Cercola 2
Changchun 2
Charlotte 2
Chengdu 2
Corbetta 2
Cormeilles-en-Parisis 2
Totale 6.488
Nome #
A gelatin-thrombin matrix topical hemostatic agent (Floseal) in combination with harmonic scalpel is effective in patients undergoing total thyroidectomy: A prospective, multicenter, single-blind, randomized controlled trial 99
ESPRESSIONE DELLE PROCHINETICINE 1 (PK1) E 2 (PK2) IN TESSUTI TIROIDEI NORMALI E PATOLOGICI E NELLA LINEA CELLULARE FB-2: CORRELAZIONE FRA L’ESPRESSIONE DELLA PK1 E LA MUTAZIONE DI BRAF. 98
Pheochromocytoma: from the bench to the surgery 95
Diagnostic evaluation of a patient with suspected Cushing’s Syndrome and hyperandrogenism: metabolic and clinical aspects for a correct differential diagnosis 84
Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. 76
ANTISPERM ANTIBODIES IN CHRIPTORCHIDISM BEFORE AND AFTER SURGICAL PROCEDURE. 73
Antiproliferative effects of SOM 230 in EPN prostate cell line 71
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 71
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH KALLMANN’S SYNDROME AND IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 68
Antisperm antibodies in prepubertal boys treated with chemotherapy for malignant or non-malignant diseases and in boys with genital tract abnormalities 67
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 67
Reattività piastrinica nella sindrome di Klinefelter 67
Impact of prophylactic central compartment neck dissection on locoregional recurrence of differentiated thyroid cancer in clinically node-negative patients: A retrospective study of a large clinical series 66
Laparoscopic adrenal surgery: Ten-year experience in a single institution 66
17-β Estradiol-Induced Activation of ERK1/2 Through Androgen Receptor–Estradiol Receptor alfa-Src Complex in Human Prostate Cells. 66
56 INHIBIN B PLASMA LEVELS AND SPERMATOGENESIS RESPONSES TO LOW DOSE RECOMBINANT HUMAN FSH IN MEN WITH HYPOGONADOTROPIC HYPOGONADISM 66
Histopathological pattern of lymph-node metastases from Oral Squamous Cell Carcinoma. An unicentric retrospective study on 146 neck dissections. 65
Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: Analysis of risk factors and review of modern trends 65
Current concepts of pheochromocytoma 64
Tongue cancer and epigenetic factors: An in-vitro study on 298 micro-RNAs 63
Multiple endocrine neoplasia, the old and the new: a mini review 62
Disfunzione sessuale femminile nella patologia tiroidea 62
Verapamil inhibits interleukin-6 and vascular endothelial growth factor production in primary cultures of keloid fibroblasts 61
Antimullerian hormone (AMH) and spermatogenesis in prepubertal onset hypogonadotropic hypogonadism treated with gonadotropin 61
Relazione tra parametri clinico-ormonali e livelli di MCP1 nella sindrome di Klinefelter 61
ANTIPROLIFERATIVE EFFECTS OF SOM230 AND OCTREOTIDE IN EPN PROSTATE CELL LINE. 61
DESENSITIZZAZIONE DELLA ADENILATO CICLASI MEDIATA DA RECETTORI MUSCARINICI IN COLTURE PRIMARIE DI CELLULE TIROIDEE DI CANE. 61
Role of pre and post-operative oral calcium and vitamin D supplements in prevention of hypocalcemia after total thyroidectomy 60
EFFETTI DEGLI ORMONI TIROIDEI SUL METABOLISMO INTERMEDIO DELLA TIROIDE STIMOLATO DA TSH, CARBACOL E TPA. 60
ANTI-ONCOGENIC ACTION OF ESTRADIOL IN EPN, A NONTRANSFORMED PROSTATE EPITHELIAL CELL LINE: EFFECTS ON TUMOR SUPPRESSORS RB AND RIZ1 60
L’INIBIZIONE DI ERK1/2 RIPRISTINA L’INIBIZIONE DELLA CRESCITA INDOTTA DA RA NELLE CELLULE PROSTATICHE MALIGNE 60
Influence of short-term selenium supplementation on the natural course of Hashimoto’s thyroiditis: clinical results of a blinded placebo-controlled randomized prospective trial 60
Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2 59
AMIODARONE INHIBITION OF THYROID STIMULATING HORMONE AND OTHER AGONISTS STIMULATION OF GLUCOSE OXIDATION AND 32P INCORPORATION INTO PHOSPHOLIPIDS IN DOG THYROID SLICES 59
REGULATION OF TISSUE TRANSGLUTAMINASE AND APOPTOSIS IN HUMAN PROSTATE EPITHELIAL CELLS BY RETINOIC ACID. 58
WNT pathway in papillary thyroid cancer analysis by immunohistochemistry(IHC) and methylation specific PCR (MSP) 58
MELATONIN ACTION IN NORMAL AND CANCER PROSTATE EPITHELIAL CELLS IN PRIMARY CULTURES. 58
thyroid carcinoma 58
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 58
Sodium butyrate/retinoic acid costimulation induces apoptosis-independent growth arrest and cell differentiation in normal and ras-transformed seminal vesicle epithelial cells unresponsive to retinoic acid 57
ALTERATION OF FLOW MEDIATED DILATATION IN PATIENTS WITH KLINEFELTER SYNDROME 57
Management of cardiovascular complications in Klinefelter syndrome patients 57
ESTROGEN RECEPTORS IN THE PROSTATE 56
ESPRESSIONE DELLA TRANSGLUTAMINASI ENDOTELIALE IN TESSUTO DI PROSTATA NORMALE E CARCINOMATOSA E DELL’ATTIVITA’ TRANSGLUTAMINASICA IN CELLULE EPITELIALI DI PROSTATA NORMALE 56
Antiproliferative effects of SOM230 on orbital fibroblasts from active Graves’ ophthalmophaty 56
SOM230 effects on primary cultures of pheochromocytoma cells. 56
FUNZIONE IPOTALAMO IPOFISI GONADE IN PAZIENTI CON SCLEROSI SISTEMICA. 56
L’AC. RETINOICO AUMENTA LA TRANSGLUTAMINASI ED INDUCE APOPTOSI NELLE CELLULE EPITELIALI PROSTATICHE IN COLTURA 56
Somatostatin receptor genes expression and effects of octreotide on orbital fibroblasts from Graves' ophthalmopathy 55
ADP ribosylation and G protein regulation in the thyroid. 55
EFFECTS OF SOMATOSTATIN ANALOGUE SOM230 ON CELL PROLIFERATION, APOPTOSIS AND CATHECOLAMINES LEVELS IN CULTURED PHEOCHROMOCYTOMA CELLS 55
VELOCITA' DI CRESCITA E LIVELLI DI IGF1 IN RAGAZZE CON PUBERTA' PRECOCE IDIOPATICA TRATTATE CON ANLOGHI DELL'LH-RH. 55
L’hCG INDUCE UNA DIFFERENTE ESPRESSIONE DEI GENI DELLA VEGF/PROKINETICINA 1 E 2 IN TESTICOLI DI RATTO PREPUBERE 55
High circulating levels of CCL2 in patients with Klinefelter's syndrome. 54
ESTROGEN RECEPTOR ALPHA AND BETA EXPRESSION IN EPITHELIAL AND STROMAL PROMARY CULTURE CELLS FROM PUBERTAL GYNECOMASTIA 54
La mutazione germinale di HABP2 è causativa del carcinoma familiare non midollare della tiroide 54
A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene 53
Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients 53
hCG INDUCES DIFFERENTIAL EXPRESSION OF ENDOCRINE GLAND-DERIVED VEGF/prokineticin 1 AND 2 GENES IN PREPUBERTAL RAT TESTIS 53
BRAF mutation and RASSF1A expression in thyroid carcinoma: a genetic and epigenetic study 53
Sexual function and sex hormones in breast cancer patients 53
Maternal hypothyroidism and subsequent neuropsychological outcome of the progeny: a family portrait 52
ELEVATED LEPTIN CONCENRATIONS IN PREPUBERTAL BOYS WITH KLINEFELTER’S SYNDROME OR CONGENITAL ANORCHIDISM 52
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy. 51
Long-term outcomes of laparoscopic adrenalectomy for Cushing disease. 51
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 51
Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study. 51
COMPORTAMENTO DEL PEPTIDE PROCOLLAGENO III N TERMINALE NEL SIERO DI PAZIENTI CON OFTALMOPATIA BASEDOWIANA CON O SENZA IPERTIROIDISMO 51
DIFFERENTIAL EXPRESSION OF PROKINETICINS IN PITUITARY ADENOMAS 51
SOMATOSTATIN RECEPTOR SUBTYPE EXPRESSION IN EPITHELIAL CELLS FROM PRIMARY CULTURES OF HUMAN NORMAL PROSTATE AND PROSTATE . 51
TEST GENETICO PRENATALE DI RET E GESTIONE DELLA GRAVIDANZA NELLA SINDROME DA NEOPLASIE ENDOCRINE MULTIPLE TIPO II A (MEN2A). 51
The role of surgery in the current management of differentiated thyroid cancer. 50
Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 triple mutation of the RET proto-oncogene. 50
Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma 50
Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells 50
Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues 50
Multifocal thoracic chordoma mimicking a paraganglioma. 50
Role of Preoperative Adrenergic Blockade with Doxazosin on Hemodynamic Control during the Surgical Treatment of Pheochromocytoma: A Retrospective Study of 48 Cases. 50
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 50
neoplasie endocrine multiple 50
SOMATOSTATIN RECEPTORS EXPRESSION AND EFFECTS OF OCTREOTIDE IN CULTURED RETROORBITAL CELLS FROM PATIENTS WITH GRAVES OPHTALMOPATHY 50
PPARγ2 EXPRESSION IS INCREASED IN CULTURED ORBITAL FIBROBLASTS FROM PATIENTS WITH GRAVES’ OPHTHALMOPATHY 50
EXPRESSION AND CELLULAR LOCALIZATION OF TUMOR SUPPRESSOR PROTEIN RIZ1 (RETINOBLASTOMA-INTERACTING ZINC-FINGER PROTEIN 1) IN PROSTATE TISSUES. 50
Normal plasma insulin-like growth factor I levels and impaired final stature in adult blind subjects 49
Rapid effects of retinoic acid on MAP Kinase activation and cAMP accumulation in human prostate ephitelia cells. 49
DIFFERENTIAL EXPRESSION OF MESSENGER RIBONUCLEIC ACID ENCODING FOR ESTROGEN RECEPTOR ALPHA AND BETA IN TISSUES AND EPITHELIAL AND STROMAL PRIMARY CULTURE CELLS FROM PUBERTAL GYNECOMASTIA 49
High circulating levels of CCL2 in patients with Klinefelter's syndrome 49
CLINICAL EXPERIENCE IN THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT THYROID INCIDENTALOMA 49
L'ANALISI DEL LIQUIDO SEMINALE CON SISTEMI AUTOMATICI ASSISTITI DA COMPUTER. 49
Laparoscopic treatment of pheochrimocytomas smaller or larger then 6 cm. A clinical retrospettive study in 44 patients. Laparoscopic adrenalectomy for pheochromocytoma 48
Sexuality in aging male 48
Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report 48
All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves' disease 48
Differential expression of estrogen receptor α and β transcripts in tissues and in primary culture cells from pubertal gynecomastia. 48
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 48
GONADOBLASTOMA RISK IN PATIENTS WITH GONADAL DYSGENESIS AND Y CHROMOSOME. 48
Tumor suppressor protein RIZ1 expression is regulated by DHT in prostate epithelial cells 48
FENOFIBRATE INDUCES ADIPOGENESIS AND INCREASES THE EXPRESSION OF HMGA2 GENE IN ORBITAL FIBROBLASTS FROM PATIENTS WITH GRAVES' OPHTHALMOPATHY 48
RAPID, NONGENOMIC RETINOID ACTIONS IN NORMAL AND MALIGNANT HUMAN PROSTATE EPITHELIAL CELLS 48
DIFFERENTIAL EXPRESSION OF RETINOIC ACID RECEPTORS IN NORMAL PROSTATE AND PROSTATE CARCINOMA. 48
Totale 5.737
Categoria #
all - tutte 38.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 11 16
2019/20201.435 253 255 34 8 240 26 277 79 102 58 84 19
2020/20212.026 111 2 227 210 318 3 253 218 8 315 250 111
2021/20221.543 102 23 16 57 567 27 28 46 67 58 103 449
2022/20233.350 295 65 39 340 344 329 3 244 1.494 28 86 83
2023/20241.021 123 46 46 118 418 151 30 68 5 13 3 0
Totale 11.137